Acupuncture and dry-needling for low back pain (Review)
Acupuncture and dry-needling for low back pain (Review)
Acupuncture and dry-needling for low back pain (Review)
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
3.2 Short-term fol<strong>low</strong>-up (up<br />
to 3 months after the end of<br />
the sessions)<br />
Other data<br />
No numeric data<br />
Comparison 8.<br />
<strong>dry</strong>-<strong>needling</strong> versus other intervention ((Sub)acute LBP < 3 months)<br />
Outcome or subgroup title<br />
No. of<br />
studies<br />
No. of<br />
participants Statistical method Effect size<br />
1 global measure (higher values are 4 Risk Ratio (M-H, R<strong>and</strong>om, 95% CI) Totals not selected<br />
better)<br />
1.1 Immediately after the end 1 Risk Ratio (M-H, R<strong>and</strong>om, 95% CI) Not estimable<br />
of the sessions<br />
1.2 Short-term fol<strong>low</strong>-up (up 4 Risk Ratio (M-H, R<strong>and</strong>om, 95% CI) Not estimable<br />
to 3 months after the end of<br />
the sessions)<br />
1.3 Intermediate-term<br />
1 Risk Ratio (M-H, R<strong>and</strong>om, 95% CI) Not estimable<br />
fol<strong>low</strong>-up (3 months to 1 year)<br />
2 Side effects / Complications 1 Risk Ratio (M-H, R<strong>and</strong>om, 95% CI) Totals not selected<br />
2.1 Short-term fol<strong>low</strong>-up (up<br />
to 3 months after the end of<br />
the sessions)<br />
1 Risk Ratio (M-H, R<strong>and</strong>om, 95% CI) Not estimable<br />
Comparison 9.<br />
acupuncture versus placebo or sham intervention (unknown / mixed duration of <strong>low</strong> <strong>back</strong> <strong>pain</strong>)<br />
Outcome or subgroup title<br />
No. of<br />
studies<br />
No. of<br />
participants Statistical method Effect size<br />
1 <strong>pain</strong> (VAS): <strong>low</strong>er values are 2 Mean Difference (IV, R<strong>and</strong>om, 95% CI) Totals not selected<br />
better<br />
1.1 Short term (immediately 2 Mean Difference (IV, R<strong>and</strong>om, 95% CI) Not estimable<br />
after end of sessions)<br />
2 global measure 1 Risk Ratio (M-H, R<strong>and</strong>om, 95% CI) Totals not selected<br />
2.1 Short-term fol<strong>low</strong>-up (up<br />
to 3 months after the end of<br />
the sessions)<br />
1 Risk Ratio (M-H, R<strong>and</strong>om, 95% CI) Not estimable<br />
<strong>Acupuncture</strong> <strong>and</strong> <strong>dry</strong>-<strong>needling</strong> <strong>for</strong> <strong>low</strong> <strong>back</strong> <strong>pain</strong> (<strong>Review</strong>)<br />
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.<br />
75